The expansion is part of BioStorages’ growth strategy and, according to CEO F John Mills, fits with increasing European demand for storage, logistics and supply chain management services.
"We are pleased to see such rapid global growth since opening our initial Germany-based facility in 2007," explained Mills, adding that “Frankfurt has been an ideal location for us to create additional alliances and partnerships with companies conducting pharmaceutical R&D”
The move follows BioStorages’ announcement that it will create 125 jobs in the US by expanding its global HQ in Indianapolis to include an additional 40,000 square foot cold-storage facility.
